This is a delivery order awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of oseltamivir phosphate (Tamiflu), an antiviral medication. The $141,052.05 firm-fixed-price delivery order is not associated with any set-aside designation. Genentech holds several established contract vehicles with federal agencies, including a $4.9 billion Federal Supply Schedule with the Department of Veterans Affairs to supply pharmaceuticals and a $27.9 million indefinite delivery contract with DLA for medical supplies and critical pharmaceuticals. The award is part of DLA's efforts to ensure the availability of essential medicines and support the Department of Defense's global health logistics network.